2022
DOI: 10.1101/2022.09.30.22280468
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Reduction in circulating monocytes correlates with persistent post-COVID pulmonary fibrosis in multi-omic comparison of long-haul COVID and IPF

Abstract: Rationale: Up to 30% of COVID-19 patients experience persistent sequelae, including dyspnea, restrictive physiology, and early radiographic signs of pulmonary fibrosis (PF). The mechanisms that provoke post-COVID progressive PF are poorly understood, and biomarkers to identify at-risk patients are urgently needed. Methods: We evaluated a cohort of 14 symptomatic COVID survivors with impaired respiratory function and imaging worrisome for developing PF, including bilateral reticulation, traction bronchiectasis … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 67 publications
0
3
0
Order By: Relevance
“…Despite progress in identifying dysregulated immune signatures associated with respiratory PASC (3,7,(9)(10)(11)(12)(13)(14)(15)(16), little is known regarding their mechanistic roles in driving pathological tissue remodeling, in part due to the lack of studies adopting "clinically relevant" animal models of post-viral lung disease.…”
Section: Introductionmentioning
confidence: 99%
“…Despite progress in identifying dysregulated immune signatures associated with respiratory PASC (3,7,(9)(10)(11)(12)(13)(14)(15)(16), little is known regarding their mechanistic roles in driving pathological tissue remodeling, in part due to the lack of studies adopting "clinically relevant" animal models of post-viral lung disease.…”
Section: Introductionmentioning
confidence: 99%
“…During the recent COVID-19 pandemic, infiltrating monocytes, macrophages and other myeloid cells were identified as key inflammatory cells in patients suffering from severe disease (Bingham et al, 2022; Chen et al, 2022; Sefik et al, 2022). In progressive COVID-19 (also known as long COVID-19) and Post-acute sequelae of COVID (PASC) profibrotic macrophages were identified with a gene signature that mirrored that of profibrotic macrophages identified in IPF (Wendisch et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…Despite progress in identifying dysregulated immune signatures associated with respiratory PASC (3,7,(9)(10)(11)(12)(13)(14)(15)(16), little is known regarding their mechanistic roles in driving pathological tissue remodeling, in part due to the lack of studies adopting "clinically relevant" animal models of post-viral lung disease.…”
Section: Introductionmentioning
confidence: 99%